Press Releases

December 13, 2017

Dicerna Public Offering of Common Stock

Alexandria Real Estate Equities, Inc. Declares Quarterly Cash Dividend of 90 Cents per Common Share up 4 Cents, or 5 Percent, over 3Q17

December 4, 2017

November 29, 2017

Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock

November 28, 2017

CollPlant Receives Substantial, Repeat Order for its Biological Ink

November 28, 2017

Cesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock

November 28, 2017

Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

November 22, 2017

Cesca Therapeutics Appoints Healthcare Investment Banking Veteran Joe E. Balagot as Senior Vice President of Corporate Development

November 21, 2017

Dicerna to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference

November 21, 2017

Nevakar Announces First Subject Dosed in its Phase 3 Clinical Trial of NVK-002 for the Treatment of Myopia in Children

November 9, 2017

Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes

November 8, 2017

Ophthotech Reports Third Quarter 2017 Financial and Operating Results

November 8, 2017

Dicerna to Present at the Stifel 2017 Healthcare Conference

November 7, 2017

Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th

October 30, 2017

Alexandria Real Estate Equities, Inc. Reports Third Quarter Ended September 30, 2017, Financial and Operating Results; Strong Internal and External Growth and
Significant Near-Term Contractual Rent Growth

October 30, 2017

Alexandria Real Estate Equities, Inc. Reports Third Quarter Ended September 30, 2017, Financial and Operating Results; Strong Internal and External Growth and
Significant Near-Term Contractual Rent Growth

October 30, 2017

Ophthotech Corporation to Report Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017

October 26, 2017

Dicerna to Report Third Quarter 2017 Financial Results and Host Conference Call on November 2, 2017

October 16, 2017

Dicerna Files Clinical Trial Application for DCR-PHXC, the Company’s Most Advanced GalXC™ Product Candidate, for Phase 1 Study in Primary Hyperoxaluria (PH)

October 3, 2017

Cesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell Separation

October 2, 2017

Nanotherapeutics Announces Name Change to Ology Bioservices, Reflecting the Company’s Ongoing Transformation into One of the Top Contract Development and Manufacturing Organizations of Vaccines and Biologics

September 27, 2017

Cesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa

September 25, 2017

Alexandria Real Estate Equities, Inc. to Hold Its Third Quarter 2017 Operating and Financial Results Conference Call and Webcast on October 31, 2017

September 25, 2017

Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017

September 20, 2017

Dicerna to Participate in Fireside Chat at the LEERINK Partners Roundtable Series

September 19, 2017

Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update

September 19, 2017

Ophthotech Provides Update on Zimura® Complement Programs for Treatment of Eye Diseases

September 13, 2017

Alexandria Real Estate Equities, Inc. Recognized for Leadership in Sustainability, One of Its Core Pillars, Earning GRESB Green Star and #1 Ranking in the U.S. in Health & Well-Being Module

September 12, 2017

Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on September 19, 2017

September 11, 2017

Alexandria Real Estate Equities, Inc. Continues to Enhance Its Critical Support of the U.S. Military with Creation of New Headquarters for The Honor Foundation in San Diego, in Partnership with the Navy SEAL Foundation

September 7, 2017

Cerus Endovascular Provides Corporate Update

September 6, 2017

Alexandria Real Estate Equities, Inc. Declares Quarterly Cash Dividend of 86 Cents per Common Share Up 6 Cents, or 8 Percent, over 3Q16

September 5, 2017

Alexandria Real Estate Equities, Inc. Announces Completion of 100% Pre-Leasing at 100 Binney Street in Cambridge, MA, Ahead of Delivery in 4Q17

September 5, 2017

Dicerna to Present at Rodman & Renshaw 19th Annual Global Investment Conference

September 5, 2017

CollPlant in Advanced Negotiations for US Private Placement of USD 5.0 Million Agreement Includes Plan for NASDAQ Uplisting

September 5, 2017

Cesca Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

August 31, 2017

Cesca Therapeutics to Participate in the CAR-TCR Summit 2017

August 24, 2017

Cesca Therapeutics Announces International Distribution Agreement with Boyalife WSN LTD.

August 14, 2017

Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration

August 10, 2017

Dicerna Reports Second Quarter 2017 Financial and Operating Results and Provides Corporate Update

August 3, 2017

Dicerna to Report Second Quarter 2017 Financial Results and Host Conference Call on August 10, 2017

July 31, 2017

Alexandria Real Estate Equities, Inc. Reports Second Quarter Ended June 30, 2017, Financial and Operating Results Strong Internal and External Growth

July 28, 2017

Cesca Therapeutics Announces Issuance of New Cellular Processing Patent Poised to Revolutionize CAR-T Cell Manufacturing

July 26, 2017

Ophthotech Reports Second Quarter 2017 Financial and Operating Results

July 26, 2017

Ophthotech Expands Focus with Development for Ophthalmic Orphan Diseases

July 17, 2017

Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (PH) and Reveals New Therapeutic Target for DCR-PHXC

July 11, 2017

MAXIMUS Declares Quarterly Cash Dividend of $0.045 per Share

July 10, 2017

Cesca Therapeutics Acquires the Cell Processing Systems of Syngen Under Asset Acquisition Agreement

July 7, 2017

Alexandria Real Estate Equities, Inc. to Hold Its Second Quarter 2017 Operating and Financial Results Conference Call and Webcast on August 1, 2017

July 6, 2017

Cerus Endovascular Receives CE Mark Approval for the Contour Neurovascular System™ for the Treatment of Intra-Cranial Aneurysms

July 6, 2017

Alexandria Real Estate Equities, Inc. Elects Michael A. Woronoff to Board of Directors

July 5, 2017

Alexandria Real Estate Equities, Inc. Announces the Alexandria Center for AgTech – RTP, Initial Phase of First Multi-Tenant, Amenity-Rich Mega R&D Campus with Greenhouses at Epicenter of Research Triangle Park, NC

June 23, 2017

Cesca Therapeutics Set to Join Russell Microcap Index

June 22, 2017

Robert J. Hennessey Appointed Chairman of the Board of Nanotherapeutics

June 21, 2017

Vigilant Biosciences Announces Further Clinical Data in Support of its OncAlert® Oral Cancer Product Line at IFOS ENT World Congress 2017 Symposium and at Annual MASCC Meeting

June 20, 2017

Peter H. Khoury, Ph.D., MBA Appointed President and Chief Executive Officer of Nanotherapeutics

June 13, 2017

Alexandria LaunchLabs, NYC’s Premier Life Science Startup Platform, Celebrates Grand Opening and Awards Inaugural $100,000 Entrepreneurship Prize

June 12, 2017

Cesca Therapeutics to Present at the 2017 Marcum Microcap Conference

June 8, 2017

Dicerna Announces Appointment of Ralf Rosskamp, M.D., as Chief Medical Officer

June 1, 2017

Dicerna to Present at Jefferies 2017 Global Healthcare Conference

May 22, 2017

Alexandria Real Estate Equities, Inc. to Ring The Opening Bell to Celebrate Its 20th Anniversary as a New York Stock Exchange Listed REIT

May 21, 2017

CollPlant Extends its European Distribution Network with Signing of New Distribution Agreement in Turkey for Vergenix® FG Wound Treatment

May 18, 2017

Cesca Therapeutics to Present at the Inaugural Cell and Gene Exchange 2017      

May 9, 2017

Semler Reports First Quarter 2017 Financial Results

May 8, 2017

CDR-Life Announces Formation of Scientific Advisory Board

May 8, 2017

Dicerna Reports First Quarter 2017 Financial and Operational Results and Provides Corporate Update

May 4, 2017

Admedus Releases Results of HSV-2 Phase lla Study 

May 2, 2017

Nanotherapeutics Bohumil s.r.o. and Praha Vaccines a.s. Finalize Transfer of Human Vaccine Manufacturing Enterprise in the Czech Republic

May 2, 2017

Admedus Receives FDA Clearance for Cardiocel 3D  

May 2, 2017

Cesca to Exhibit at the 25th International Society for Cellular Therapy (ISCT) Annual Meeting

May 1, 2017

Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2017, Financial and Operating Results Strong Internal and External Growth

May 1, 2017

Dicerna to Report First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017

April 27, 2017

Pendant Biosciences Announces Acceptance into JLABS @ Toronto

Rx Communications Group, LLC